Cargando…
Diagnosis and Prognosis of Prostate Cancer from Circulating Matrix Metalloproteinases and Inhibitors
Although prostate cancer (PCa) is the sixth most common type of neoplasm in the world and the second in prevalence among men (10% of all cases), there is shortage of studies focused on primary prevention of the disorder as well as little understanding on its pathophysiology. Currently, the PCa scree...
Autores principales: | El-Chaer, William Khalil, Moraes, Clayton Franco, Nóbrega, Otávio Toledo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6079523/ https://www.ncbi.nlm.nih.gov/pubmed/30123587 http://dx.doi.org/10.1155/2018/7681039 |
Ejemplares similares
-
Serum Levels of Matrix Metalloproteinase-1 in Brazilian Patients with Benign Prostatic Hyperplasia or Prostate Cancer
por: El-Chaer, William Khalil, et al.
Publicado: (2020) -
Matrix Metalloproteinase-1 Gene Polymorphism Associated with Ultrasound-Assessed Carotid Thickness among Older Adults
por: Morais Junior, Gilberto Santos, et al.
Publicado: (2018) -
Circulating Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Cardiac Amyloidosis
por: Tanaka, Komei, et al.
Publicado: (2013) -
Study of matrix metalloproteinases and their inhibitors in prostate cancer
por: Escaff, S, et al.
Publicado: (2010) -
Roles of Matrix Metalloproteinases and Their Natural Inhibitors in Prostate Cancer Progression
por: Gong, Yixuan, et al.
Publicado: (2014)